Advertisement

Prognosis and Prevention of Renal Failure Induced by Toxins

  • John F. Maher

Abstract

Deleterious functional effects caused by nephrotoxins can result when such noxious agents induce renal failure de novo, either acutely or chronically, or when preexisting impairment of renal function is aggravated by toxin exposure. Severe acute renal failure can usually be recognized easily. Moreover, the association with acute toxin exposure is often apparent, although its role may not be appreciated in patients with coexistent problems such as septicemia and shock. Chronic nephrotoxicity and toxicity superimposed on chronic renal impairment are frequently more difficult to diagnose.

Keywords

Acute Renal Failure Interstitial Nephritis Nephrogenic Diabetes Insipidus Fanconi Syndrome Acute Interstitial Nephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Maher JF: Toxic and irradiation nephropathies, in Earley LE, Gottschalk CW (eds): Strauss and Welt’s Diseases of the Kidney. Boston, Little, Brown and Co, 1978, pp 1431–1474.Google Scholar
  2. 2.
    Harmon WE, Cohen HJ, Schneeberger EE, et al: Chronic renal failure in children treated with methyl CCNU. N Engl J Med 300: 1200–1203, 1979.PubMedCrossRefGoogle Scholar
  3. 3.
    Takacs FJ, Tomkiewicz AM, Merrill JP: Amphotericin B nephrotoxicity with irreversible renal failure. Ann Intern Med 59: 716–720, 1963.PubMedGoogle Scholar
  4. 4.
    Lewers DT, Mathew TH, Maher JF, et al: Long-term follow-up of renal function and histology after acute tubular necrosis. Ann Intern Med 73: 523–529, 1970.PubMedGoogle Scholar
  5. 5.
    Mitchell JR, McMurtry RJ, Statham CN, et al: Molecular basis for several drug induced nephropathies. Am J Med 62: 518–526, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Luft FC, Block R, Sloan RS, et al: Comparative nephrotoxicity of aminoglycoside antibiotics in rats. J Infect Dis 138: 541–545, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Kimberly RP, Bowden RE, Keiser HR, et al: Reduction of renal function by newer nonsteroidal anti-inflammatory drugs. Am J Med 64: 804–807, 1978.PubMedCrossRefGoogle Scholar
  8. 8.
    Gary NE, Dodelson R, Eisinger RP: Indomethacin-associated acute renal failure. Am J Med 69: 135–136, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Lawrence JR: Clinical use of corticosteroids in renal disease. Drugs 8: 438–447, 1974.PubMedCrossRefGoogle Scholar
  10. 10.
    Emmerson BT: Chronic lead nephropathy. The diagnostic use of calcium EDTA and the association with gout. Aust Ann Med 12: 310–324, 1963.PubMedGoogle Scholar
  11. 11.
    Farebrother DA, Hatfield P, Simmonds HA, et al: Experimental crystal nephropathy (one year study in the pig). Clin Nephrol 4: 243–250, 1975.Google Scholar
  12. 12.
    Pitman SW, Frei E, III: Weekly methotrexate-calcium leucovorin rescue: Effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin’s lymphoma. Cancer Treat Rep 61: 695–701, 1977.PubMedGoogle Scholar
  13. 13.
    Curtis JR: Drug induced renal disease. Drugs 18: 377–391, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Gonwa TA, Corbett WT, Schey HM, et al: Analgesic associated nephropathy and transitional cell carcinoma of the urinary tract. Ann Intern Med 93: 249–252, 1980.PubMedGoogle Scholar
  15. 15.
    Evan AP, Gardner KD, Jr: Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 15: 7–19, 1979.PubMedCrossRefGoogle Scholar
  16. 16.
    Setter JG, Maher JF, Schreiner GE: Acute renal failure following cholecystography. JAMA 184: 102–110, 1963.PubMedCrossRefGoogle Scholar
  17. 17.
    Byrd L, Sherman RL: Radiocontrast-induced acute renal failure: A clinical and pathophysiologic review. Medicine 58: 270–279, 1979.PubMedCrossRefGoogle Scholar
  18. 18.
    Tune BM, Wu KY, Longerbeam DF, et al: Transport and toxicity of cephaloridine in the kidney. Effect of furosemide p-aminohippurate and saline diuresis. J Pharmacol Exp Ther 202: 472–478, 1977.PubMedGoogle Scholar
  19. 19.
    Bidani A, Churchill D, Fleischmann L: Sodium-chloride induced protection in nephrotoxic acute renal failure: Independence from renin. Kidney Int 16: 481–490, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    Wainscoat JS, Finn R: Possible role of laxatives in analgesic nephropathy. Br Med J 4: 697698, 1974.Google Scholar
  21. 21.
    Barza M: The nephrotoxicity of cephalosporins: An overview. J Infect Dis 137: S60–573, 1978.PubMedCrossRefGoogle Scholar
  22. 22.
    Wade JC, Smith CR, Petty BG, et al: Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet 2: 604–606, 1978.PubMedCrossRefGoogle Scholar
  23. 23.
    Agarwal BN, Cabebe FG, Hoffman BI: Diphenylhydantoin-induced acute renal failure. Nephron 18: 249–251, 1977.PubMedCrossRefGoogle Scholar
  24. 24.
    Cronin RE: Aminoglycoside nephrotoxicity: Pathogenesis and prevention. Clin Nephrol 11: 251–256, 1979.PubMedGoogle Scholar
  25. 25.
    Bennett WM, Plamp CE, Gilbert DN, et al: The influence of dosage regimen on experimental gentamicin nephrotoxicity: Dissociation of peak serum levels from renal failure. J Infect Dis 140: 576–580, 1979.PubMedCrossRefGoogle Scholar
  26. 26.
    Mattson K, Riska H, Forsstrom J, et al: Acute renal failure following rifampicin administration. Scand J Respir Dis 55: 291–297, 1974.PubMedGoogle Scholar
  27. 27.
    Phillips TL, Ross BS: A quantitative technique for measuring renal damage after irradiation. Radiology 109: 457–462, 1973.PubMedGoogle Scholar
  28. 28.
    Milman N: Renal failure associated with gentamicin therapy. Acta Med Scand 196: 87–91, 1974.PubMedCrossRefGoogle Scholar
  29. 29.
    Dubach UC, Levy PS, Rosner B, et al: Relation between regular intake of phenacetincontaining analgesics and laboratory evidence for urorenal disorders in a working female population of Switzerland. Lancet 1: 539–543, 1975.PubMedCrossRefGoogle Scholar
  30. 30.
    Nanra RS, Fairley KF, Kincaid-Smith P: Recovery of function in patients with analgesic nephropathy. Aust Ann Med 19: 195–196, 1970.Google Scholar
  31. 31.
    Finn R, Fennerty AG, Ahmad R: Hydrocarbon exposure and glomerulonephritis. Clin Nephrol 14: 173–175, 1980.PubMedGoogle Scholar
  32. 32.
    Ho PWL, Pien FD, Kominami N: Massive amikacin “overdosage.” Ann Intern Med 91: 227228, 1979.Google Scholar
  33. 33.
    Winchester JF, Gelfand MC, Knepshield JH, et al: Dialysis and hemoperfusion of poisons and drugs—update. Trans Am Soc Artif Intern Organs 23: 762–842, 1977.PubMedCrossRefGoogle Scholar
  34. 34.
    Maher JF, Rath CE, Schreiner GE: Hyperuricemia complicating leukemia: Treatment with allopurinol and dialysis. Arch Intern Med 123: 198–200, 1969.PubMedCrossRefGoogle Scholar
  35. 35.
    Maher JF, Bryan CW, Ahearn DJ: Prognosis of chronic renal failure II. Factors affecting survival. Arch Intern Med 135: 273–278, 1975.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • John F. Maher
    • 1
  1. 1.Division of NephrologyUniformed Services University of the Health Sciences School of MedicineBethesdaUSA

Personalised recommendations